Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Invest Dermatol ; 143(7): 1138-1146.e12, 2023 07.
Article in English | MEDLINE | ID: mdl-36708947

ABSTRACT

Morphea is characterized by initial inflammation followed by fibrosis of the skin and soft tissue. Despite its substantial morbidity, the pathogenesis of morphea is poorly studied. Previous work showed that CXCR3 ligands CXCL9 and CXCL10 are highly upregulated in the sera and lesional skin of patients with morphea. We found that an early inflammatory subcutaneous bleomycin mouse model of dermal fibrosis mirrors the clinical, histological, and immune dysregulation observed in human morphea. We used this model to examine the role of the CXCR3 chemokine axis in the pathogenesis of cutaneous fibrosis. Using the REX3 (Reporting the Expression of CXCR3 ligands) mice, we characterized which cells produce CXCR3 ligands over time. We found that fibroblasts contribute the bulk of CXCL9-RFP and CXCL10-BFP by percentage, whereas macrophages produce high amounts on a per-cell basis. To determine whether these chemokines are mechanistically involved in pathogenesis, we treated Cxcl9-, Cxcl10-, or Cxcr3-deficient mice with bleomycin and found that fibrosis is dependent on CXCL9 and CXCR3. Addition of recombinant CXCL9 but not CXCL10 to cultured mouse fibroblasts induced Col1a1 mRNA expression, indicating that the chemokine itself contributes to fibrosis. Taken together, our studies provide evidence that CXCL9 and its receptor CXCR3 are functionally required for inflammatory fibrosis.


Subject(s)
Dermatitis , Scleroderma, Localized , Humans , Animals , Mice , Chemokine CXCL10/genetics , Chemokine CXCL10/metabolism , Up-Regulation , Ligands , Chemokine CXCL9/genetics , Chemokine CXCL9/metabolism , Fibrosis , Inflammation , Fibroblasts/metabolism , Bleomycin/toxicity , Receptors, CXCR3/genetics , Receptors, CXCR3/metabolism
2.
Ann Card Anaesth ; 24(3): 411-414, 2021.
Article in English | MEDLINE | ID: mdl-34269284

ABSTRACT

Myocardial abscess is a suppurative infection of myocardium, endocardium, native or prosthetic valves, perivalvular structures and cardiac conduction system. It develops in about 20% of patients with infective endocarditis. Due to avascular and fibrous structures, valvular regions are commonly involved. More precisely, aortic valve (AV) rings area; native or prosthetic valve is usually affected. Occurrence of myocardial abscess within free wall of the left ventricle (LV) without any evidence of infective endocarditis is a rare phenomenon; and infrequently reported in medical literature. We report a case of myocardial abscess cavity within the anterior wall of the LV, in a patient who underwent open heart surgery for severe AV stenosis. This was an incidental intraoperative transesophageal echocardiography (TEE) finding without any other evidence of infective endocarditis. The stenotic AV was replaced, along with surgical drainage and closure of the cavity. Postoperatively, patient was managed on empirical antibiotics according to infective endocarditis guidelines.


Subject(s)
Heart Valve Diseases , Heart Valve Prosthesis , Abscess/diagnostic imaging , Abscess/surgery , Echocardiography, Transesophageal , Humans , Incidental Findings , Myocardium
5.
J Invest Dermatol ; 139(4): 769-778, 2019 04.
Article in English | MEDLINE | ID: mdl-30423329

ABSTRACT

Tissue resident memory T cells (Trm) form in the skin in vitiligo and persist to maintain disease, as white spots often recur rapidly after discontinuing therapy. We and others have recently described melanocyte-specific autoreactive Trm in vitiligo lesions. Here, we characterize the functional relationship between Trm and recirculating memory T cells (Tcm) in our vitiligo mouse model. We found that both Trm and Tcm sensed autoantigen in the skin long after stabilization of disease, producing IFN-γ, CXCL9, and CXCL10. Blockade of Tcm recruitment to the skin with FTY720 or depletion of Tcm with low-dose Thy1.1 antibody reversed disease, indicating that Trm cooperate with Tcm to maintain disease. Taken together, our data provide characterization of skin memory T cells in vitiligo, demonstrate that Trm and Tcm work together during disease, and indicate that targeting their survival or function may provide novel, durable treatment options for patients.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Immunologic Memory/immunology , Melanocytes/immunology , Skin/immunology , Vitiligo/immunology , Animals , Disease Models, Animal , Flow Cytometry , Humans , Melanocytes/pathology , Mice , Mice, Transgenic , Skin/pathology , Vitiligo/pathology
6.
Sci Transl Med ; 10(450)2018 07 18.
Article in English | MEDLINE | ID: mdl-30021889

ABSTRACT

Vitiligo is an autoimmune disease of the skin mediated by CD8+ T cells that kill melanocytes and create white spots. Skin lesions in vitiligo frequently return after discontinuing conventional treatments, supporting the hypothesis that autoimmune memory is formed at these locations. We found that lesional T cells in mice and humans with vitiligo display a resident memory (TRM) phenotype, similar to those that provide rapid, localized protection against reinfection from skin and mucosal-tropic viruses. Interleukin-15 (IL-15)-deficient mice reportedly have impaired TRM formation, and IL-15 promotes TRM function ex vivo. We found that both human and mouse TRM express the CD122 subunit of the IL-15 receptor and that keratinocytes up-regulate CD215, the subunit required to display the cytokine on their surface to promote activation of T cells. Targeting IL-15 signaling with an anti-CD122 antibody reverses disease in mice with established vitiligo. Short-term treatment with anti-CD122 inhibits TRM production of interferon-γ (IFNγ), and long-term treatment depletes TRM from skin lesions. Short-term treatment with anti-CD122 can provide durable repigmentation when administered either systemically or locally in the skin. On the basis of these data, we propose that targeting CD122 may be a highly effective and even durable treatment strategy for vitiligo and other tissue-specific autoimmune diseases involving TRM.


Subject(s)
Antibodies, Blocking/therapeutic use , Interleukin-15/metabolism , Signal Transduction , Vitiligo/drug therapy , Vitiligo/immunology , Animals , Antibodies, Blocking/administration & dosage , Antibodies, Blocking/pharmacology , Antigens, CD/metabolism , CD8-Positive T-Lymphocytes/immunology , Disease Models, Animal , Epidermis/immunology , Humans , Immunologic Memory , Interferon-gamma/metabolism , Melanocytes/metabolism , Mice, Inbred C57BL , Phenotype , Receptors, Interleukin-15/metabolism , Vitiligo/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...